Endlyz Therapeutics
Biotechnology Research • 
United States • 1-10 Employees
Company overview
| Headquarters | United States |
| Website | |
| NAICS | 541714 |
| Founded | 2021 |
| Employees | 1-10 |
| Socials |
Key Contact at Endlyz Therapeutics
Floriana Licitra
Director, Research Biology
Endlyz Therapeutics Email Formats
Endlyz Therapeutics uses 2 email formats. The most common is {first name} (e.g., john@endlyz.com), used 75% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@endlyz.com | 75% |
{first initial} | j@endlyz.com | 25% |
About Endlyz Therapeutics
Endlyz Therapeutics Inc. and Endlyz UK Ltd (together ‘Endlyz’) are developing disease-modifying therapeutics that restore endo-lysosomal function and abrogate neurodegeneration in Parkinson’s disease and other dementias. By leveraging extensive industry experience, a robust investor syndicate, and academic collaborations that provide access to advanced technologies on an exclusive basis, Endlyz is well positioned to lead the industry in our programmes. The company is open to discuss collaborations and in-licensing of complimentary programmes.
Endlyz Therapeutics revenue & valuation
| Annual revenue | $598,885 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $2,000,000 |
| Total funding | $2,200,000 |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Endlyz Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Norway
Sweden
CanadaFrequently asked questions
4.8
40,000 users
